Officer exercised or converted 2,175 ADMA derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Mar 9, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Mar 11, 2026
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001140361-26-008905
Added to OQROOct 6, 2026, 9:54 PM UTC Data qualityVerified: identifiers matched exactly IssuerADMA BIOLOGICS, INC. Reporting personKaitlin M. Kestenberg-messina Officer titleCOO and SVP, Compliance SecurityStock Option (right to buy) TableDerivative (Table II) Transaction dateMar 9, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- The incentive stock options were granted to the Reporting Person on July 19, 2021, and are fully vested.
Around the same time
Traded Apr 1 · filed 3 days later
Routine share withholding; mechanical by default.
Traded Mar 13 · filed 5 days later
Derivative exercise or conversion — not an open-market buy.
Traded Mar 17 · filed 1 day later
Gift or transfer — classified separately from trades.